Elisabetta Zulato - Concepedia

Author

Elisabetta Zulato

Istituto Oncologico Veneto ORCID

Also Known As

E Zulato, E. Zulato, Elisabetta Zulato, Zulato, Elisabetta

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Istituto Oncologico Veneto University of Padua Istituti di Ricovero e Cura a Carattere Scientifico University of Turin Università Cattolica del Sacro Cuore

About

Elisabetta Zulato is an author at Istituto Oncologico Veneto specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	364
2	Cell Biology	4	4	282
3	Health Sciences	1	1	68
4	Cellular Physiology	1	1	68
5	Immunology	1	1	22

Elisabetta Zulato

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation Anna Pastò, Chiara Bellio, Giorgia Pilotto, Oncotarget	2014	282
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC Massimo Moro, Elisa Caiola, Monica Ganzinelli, Journal of Thoracic Oncology Prevents ResistanceCell RegulationMedicineApoptosisCell Death	2018	103
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization Giorgia Nardo, Elena Favaro, Matteo Curtarello, Cancer Research	2011	74
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells Matteo Curtarello, Elisabetta Zulato, Giorgia Nardo, Cancer Research Tumor MetabolismOncologyAngiogenesisMedicineAnti-vegf Therapy	2014	70
ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to Apoptosis Elisabetta Zulato, Francesca Favaretto, Caterina Veronese, PLoS ONE ApoptosisCell DeathPathologyAlms1 GeneCell Proliferation	2011	68
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab Laura Bonanno, Angela De Paoli, Elisabetta Zulato, Clinical Cancer Research	2017	53
Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab Elisabetta Zulato, Francesca Bergamo, Angela De Paoli, British Journal of Cancer	2014	48
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors Annalisa Trenti, Elisabetta Zulato, Lorenza Pasqualini, British Journal of Pharmacology	2017	43
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome Alberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, Translational Lung Cancer Research	2021	43
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation Elisabetta Zulato, Francesco Ciccarese, Valentina Agnusdei, Biochemical Pharmacology Redox SignalingLkb1 LossMedicinePharmacologyCancer Cell Biology	2018	41

Page 1